Your browser doesn't support javascript.
loading
Virus evolution and reduced viral viability during treatment of persistent COVID-19 Omicron BA.5 infection in an immunocompromised host.
Kaya, Hiroyasu; Tani, Hideki; Inasaki, Noriko; Yazawa, Shunsuke; Itamochi, Masae; Higashi, Daiki; Tsuji, Noriaki; Nakamura, Masahiko; Oishi, Kazunori.
Afiliación
  • Kaya H; Toyama Prefectural Central Hospital, Toyama, Japan. Electronic address: hiro-kaya@kit.hi-ho.ne.jp.
  • Tani H; Toyama Institute of Health, Toyama, Japan.
  • Inasaki N; Toyama Institute of Health, Toyama, Japan.
  • Yazawa S; Toyama Institute of Health, Toyama, Japan.
  • Itamochi M; Toyama Institute of Health, Toyama, Japan.
  • Higashi D; Toyama Prefectural Central Hospital, Toyama, Japan.
  • Tsuji N; Toyama Prefectural Central Hospital, Toyama, Japan.
  • Nakamura M; Toyama Prefectural Central Hospital, Toyama, Japan.
  • Oishi K; Toyama Institute of Health, Toyama, Japan.
Int J Infect Dis ; 136: 146-148, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37722481
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article